: Outcome of the patients who became PCR positive after achieving molecular remission post-DLI.

(A) One patient evolved to blastic phase and died. (B) Two patients (only one is represented) fulfilled the criteria for molecular relapse and were treated with a further dose of donor lymphocytes that restored remission. (C) One patient showed persistently fluctuating low levels of BCR-ABL transcripts but did not fulfill the criteria for molecular relapse.